A Agilent Technologies Inc.

Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye

(NYSE: A) announced today that , has received the Agilent 2024 Early Career Professor Award for his contribution to environmental health and sustainability, developing green analytical technologies, methods, or laboratory working environments. Dr. Adeleye is an assistant professor in the Department of Earth and Environmental Engineering at .

The 2024 award focused on contributions to academic research in sustainability and green chemistry. Dr. Adeleye’s research focuses on improving environmental health and sustainability through green approaches, and specifically, using engineered nanoparticles made of earth-abundant, essential elements such as iron, sulfur, and silicon to remediate environmental matrices contaminated with persistent pollutants like arsenic, lead, and per- and polyfluoroalkyl substances (PFAS). Additionally, Dr. Adeleye is studying ways to combine remediation with carbon sequestration in soil to reduce the environmental impact of these approaches.

“I am deeply honored and grateful to receive this esteemed award, which recognizes my research group’s efforts and inspires us to continue striving for excellence,” said Dr. Adeleye. “Persistent environmental contaminants, like heavy metals, pose a significant threat to food safety and human health. "We will continue to expand our understanding of how heavy metals interact with engineered surfaces in natural environments, supporting our long-term goal of developing sustainable solutions to heavy metal contamination. The support from Agilent will undoubtedly help us achieve this important ambition.”

“Agilent is committed to advancing environmental sustainability and empowering innovation that accelerates the development of eco-friendly solutions by supporting researchers who are pioneering green analytical technologies and sustainable laboratory practices,” said Nahid Chalyavi, associate vice president of University Relations and External Research at Agilent. “This year’s award recipient, Dr. Adeleye, is at the forefront of integrating environmental chemistry, engineering, and material science. His research focuses on understanding the reactions between pollutants and reactive surfaces in environmental systems and applying this knowledge to remediate polluted environments.”

Dr. Adeleye’s research supports the effort of the US Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) to tackle the widespread occurrence of toxic heavy metals in crop-based foods through the “Closer-to-Zero” Initiative. The National Science Foundation (NSF) and the Centers for Disease Control and Prevention (CDC) have also supported his work.

The Agilent Early Career Professor Award is an annual program that recognizes and supports promising research from professors who, early in their careers, show outstanding potential for future research in areas of importance to the communities Agilent serves. This award underscores Agilent's commitment to furthering research through the company's products and services, financial support, and collaborative engagement by Agilent scientists and engineers. Further information about the program is available at .

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs approximately 18,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on and .

EN
20/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

 PRESS RELEASE

Agilent Presents Solutions Innovation Research Awards to Aarhus Univer...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced Solutions Innovation Research Awards (SIRA) have been presented to Professor Anders Bentien of , Professor Walter Gössler of , and Professor Gregory Offer of . These separate awards recognize their outstanding contributions to battery research. Developing new materials for more efficient and durable batteries is essential to reducing fossil fuel reliance and meeting global energy storage needs. Given the limited supply of critical metals like lithium, it is crucial to focus on pioneering new materials and recovering and reusin...

 PRESS RELEASE

Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conferenc...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Bob McMahon will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 14, 2025, at 9:45 a.m. Pacific time. A live audio webcast and replay of the presentation will be available on the . About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full ran...

 PRESS RELEASE

Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives Eur...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for (Code SK005). This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices (IVDR) 1. PD-L1 IHC 28-8 pharmDx is approved for exclusive use with the advanced staining solution. Agilent’s PD-L1 IHC 28-8 pharmDx (Code SK005) provides clinically relevant information about PD-L1 expression – a critical biomarke...

 PRESS RELEASE

Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.70 billion for the fourth quarter ended October 31, 2024, an increase of 0.8% reported and a decline of 0.3% core(1) compared to the fourth quarter of 2023. Fourth-quarter GAAP net income was $351 million, or $1.22 per share. This compares with $475 million, or $1.62 per share, in the fourth quarter of fiscal year 2023. Non-GAAP(2) net income was $418 million, or $1.46 per share during the quarter, compared with $404 million or $1.38 per share during the fourth quarter a year ago. “The A...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch